HitGen Inc. A
HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technologies; emerging technology platforms for synthetic therapeutic oligonucleotide technology; and targeted protein degradation technolog… Read more
Market Cap & Net Worth: HitGen Inc. A (688222)
HitGen Inc. A (SHG:688222) has a market capitalization of $1.41 Billion (CN¥10.33 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #8610 globally and #1655 in its home market, demonstrating a -2.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HitGen Inc. A's stock price CN¥25.78 by its total outstanding shares 400680000 (400.68 Million).
HitGen Inc. A Market Cap History: 2020 to 2026
HitGen Inc. A's market capitalization history from 2020 to 2026. Data shows change from $1.63 Billion to $1.41 Billion (-9.52% CAGR).
HitGen Inc. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HitGen Inc. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.58x
HitGen Inc. A's market cap is 1.58 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
13.10x
HitGen Inc. A's market cap is 13.10 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.63 Billion | $243.60 Million | $64.02 Million | 6.69x | 25.46x |
| 2021 | $1.27 Billion | $311.06 Million | $63.38 Million | 4.09x | 20.09x |
| 2022 | $733.07 Million | $329.65 Million | $25.27 Million | 2.22x | 29.01x |
| 2023 | $815.18 Million | $371.32 Million | $40.72 Million | 2.20x | 20.02x |
| 2024 | $672.78 Million | $426.99 Million | $51.36 Million | 1.58x | 13.10x |
Competitor Companies of 688222 by Market Capitalization
Companies near HitGen Inc. A in the global market cap rankings as of March 19, 2026.
Key companies related to HitGen Inc. A by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
HitGen Inc. A Historical Marketcap From 2020 to 2026
Between 2020 and today, HitGen Inc. A's market cap moved from $1.63 Billion to $ 1.41 Billion, with a yearly change of -9.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.41 Billion | +9.94% |
| 2025 | CN¥1.28 Billion | +90.34% |
| 2024 | CN¥672.78 Million | -17.47% |
| 2023 | CN¥815.18 Million | +11.20% |
| 2022 | CN¥733.07 Million | -42.45% |
| 2021 | CN¥1.27 Billion | -21.87% |
| 2020 | CN¥1.63 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of HitGen Inc. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.41 Billion USD |
| MoneyControl | $1.41 Billion USD |
| MarketWatch | $1.41 Billion USD |
| marketcap.company | $1.41 Billion USD |
| Reuters | $1.41 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.